Report Detail

Pharmaceuticals & Healthcare Spinal Cord Injury Global Clinical Trials Review, H2, 2018

  • RnM2449884
  • |
  • 28 September, 2018
  • |
  • Global
  • |
  • 225 Pages
  • |
  • GlobalData
  • |
  • Pharmaceuticals & Healthcare

Table of Contents

    Table of Contents 2

      List of Tables 3

        List of Figures 4

          Report Guidance 5

            GlobalData Clinical Trials Report Coverage 6

              Clinical Trials by Region 7

                Clinical Trials and Average Enrollment by Country 8

                  Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

                    Top Five Countries Contributing to Clinical Trials in Europe 12

                      Top Countries Contributing to Clinical Trials in North America 13

                        Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

                          Top Five Countries Contributing to Clinical Trials in Central and South America 15

                            Clinical Trials by G7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 16

                              Clinical Trials by Phase in G7 Countries 18

                                Clinical Trials in G7 Countries by Trial Status 19

                                  Clinical Trials by E7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 20

                                    Clinical Trials by Phase in E7 Countries 22

                                      Clinical Trials in E7 Countries by Trial Status 23

                                        Clinical Trials by Phase 24

                                          In Progress Trials by Phase 25

                                            Clinical Trials by Trial Status 26

                                              Clinical Trials by End Point Status 27

                                                Subjects Recruited Over a Period of Time 28

                                                  Clinical Trials by Sponsor Type 29

                                                    Prominent Sponsors 30

                                                      Top Companies Participating in Spinal Cord Injury Therapeutics Clinical Trials 32

                                                        Prominent Drugs 34

                                                          Latest Clinical Trials News on Spinal Cord Injury 35

                                                            Jun 01, 2018: Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results 35

                                                              Clinical Trial Profile Snapshots 36

                                                                Appendix 223

                                                                  Abbreviations 223

                                                                    Definitions 223

                                                                      Research Methodology 224

                                                                        Secondary Research 224

                                                                          About GlobalData 225

                                                                            Contact Us 225

                                                                              Disclaimer 225

                                                                                Source 225

                                                                                Spinal Cord Injury Global Clinical Trials Review, H2, 2018

                                                                                Summary

                                                                                GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2018" provides an overview of Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

                                                                                The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

                                                                                *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

                                                                                Scope

                                                                                - The report provides a snapshot of the global clinical trials landscape
                                                                                - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
                                                                                - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
                                                                                - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
                                                                                - The Report provides enrollment trends for the past five years
                                                                                - Report provides latest news for the past three months

                                                                                *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

                                                                                Reasons to buy

                                                                                - Assists in formulating key business strategies with regards to investment
                                                                                - Helps in identifying prominent locations for conducting clinical trials which saves time and cost
                                                                                - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
                                                                                - Supports understanding of trials count and enrollment trends by country in global therapeutics market
                                                                                - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
                                                                                - Facilitates clinical trial assessment of the indication on a global, regional and country level

                                                                                *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


                                                                                Summary:
                                                                                Get latest Market Research Reports on Spinal Cord Injury . Industry analysis & Market Report on Spinal Cord Injury is a syndicated market report, published as Spinal Cord Injury Global Clinical Trials Review, H2, 2018. It is complete Research Study and Industry Analysis of Spinal Cord Injury market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                Last updated on

                                                                                REPORT YOU MIGHT BE INTERESTED

                                                                                Purchase this Report

                                                                                $2,500.00
                                                                                $5,000.00
                                                                                $7,500.00
                                                                                1,871.86
                                                                                3,743.71
                                                                                5,615.57
                                                                                2,099.64
                                                                                4,199.28
                                                                                6,298.92
                                                                                260,635.00
                                                                                521,270.00
                                                                                781,905.00
                                                                                184,646.25
                                                                                369,292.50
                                                                                553,938.75
                                                                                Credit card Logo

                                                                                Related Reports


                                                                                Reason to Buy

                                                                                Request for Sample of this report